title: Reflections on the Innovative Medicines Initiative.
abstract: The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public-private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
authors.affiliation: Innovative Medicines Initiative, B-1060 Brussels, Belgium. michel.goldman@imi.europa.eu
authors.forename: Michel
authors.initials: M
authors.lastname: Goldman
mesh_terms: D003299:Cooperative Behavior; D015195:Drug Design; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D017146:Models, Organizational; D055818:Public-Private Sector Partnerships / Q000458:organization & administration; D012106:Research / Q000458:organization & administration